PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Worst Case Consideration, page-20

  1. 9,704 Posts.
    lightbulb Created with Sketch. 1234
    interesting thread. perhaps next time you consider sharing your own thesis or areas of further consideration up front
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.